Cold & Cough Remedies (Pharmacies) - Uzbekistan

  • Uzbekistan
  • Revenue in the Cold & Cough Remedies market is projected to reach US$84.31m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 14.43%, resulting in a market volume of US$165.40m by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.36 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Uzbekistan has been experiencing significant growth in recent years. Customer preferences have shifted towards over-the-counter remedies, leading to an increase in sales for pharmacies. This trend can be attributed to several factors, including changing consumer lifestyles and an increased awareness of self-care.

Customer preferences:
In Uzbekistan, there has been a noticeable shift in customer preferences towards over-the-counter cold and cough remedies. This can be attributed to the convenience and accessibility of these products, as well as the increasing awareness among consumers about self-care. People are becoming more proactive in managing their health and are seeking quick and effective solutions for common ailments like colds and coughs. As a result, pharmacies have seen a surge in demand for these remedies, leading to a growth in the market.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Uzbekistan is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are opting for natural alternatives. This trend is driven by a growing preference for holistic health and wellness solutions. Pharmacies have responded to this demand by stocking a wider range of natural and herbal remedies, catering to the evolving needs of their customers. Another trend in the market is the rising popularity of combination remedies. These are products that offer relief for multiple symptoms, such as a combination of cough suppressant and decongestant. This trend can be attributed to the convenience and cost-effectiveness of these products, as they provide relief for multiple symptoms in a single medication. Pharmacies have capitalized on this trend by offering a variety of combination remedies, providing customers with a one-stop solution for their cold and cough needs.

Local special circumstances:
One of the local special circumstances impacting the Cold & Cough Remedies market in Uzbekistan is the prevalence of cold and flu during the winter months. The country experiences cold winters, which leads to a higher incidence of respiratory illnesses. This creates a higher demand for cold and cough remedies during this time of the year. Pharmacies in Uzbekistan have adapted to this seasonal demand by ensuring an adequate supply of cold and cough remedies during the winter months.

Underlying macroeconomic factors:
The growth of the Cold & Cough Remedies market in Uzbekistan can also be attributed to favorable macroeconomic factors. The country has experienced steady economic growth in recent years, leading to an increase in disposable income. This has resulted in higher healthcare spending, including the purchase of over-the-counter remedies. Additionally, the government has implemented policies to promote the development of the pharmaceutical industry, which has contributed to the growth of the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Uzbekistan is experiencing growth due to changing customer preferences, including a shift towards over-the-counter remedies and an increasing demand for natural and herbal products. Pharmacies have responded to these trends by offering a wider range of products, including combination remedies. Local special circumstances, such as the prevalence of cold and flu during the winter months, also contribute to the growth of the market. Favorable macroeconomic factors, including steady economic growth and government policies, further support the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)